Manufacturers are pushing for higher prices overseas, but face political and economic resistance.

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...

Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...

In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...

Scientists have collaborated to develop a new class of highly precise filtration membranes. The research, published in the ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Sen. Travis Fitzwater, R-Holts Summit, continues to seek regulations on how pharmacy benefit managers (PBMs) can operate in Missouri.